PHARMACEUTICAL ZONE DEVELOPMENT
ARABOKKA-HAMBANTOTA
Hambantota
LOCATION
400 Acres
Land Extent
USD 5 Mn
MINIMUM Investment
Project Overview
The BOI, in order to support developing new industry verticals via import substitution and exports, is establishing a state-of-the-art pharmaceutical zone in Arabokka, Hambantota. This dedicated Pharmaceutical Manufacturing Zone plans to meet 40% of the domestic demand for pharmaceutical products by locally manufactured drugs while creating a pathway to export earnings as import substitution by 2025. The Zone will be declared as a “Strategic Development Project” (SDP) and strategic pharmaceutical investments established within the proposed zone will be eligible for benefits under the SDP Act. This State–of–Art zone will be designed to International standards and accreditations. This specifically tailored zone will make a conducive and liveable business environment to globally renewed pharmaceutical brands to bring the latest technological advances to manufacture pharmaceutical products.
- Pre-approved zone: All environmental clearances to manufacture a full suite of pharmaceutical products and fast tracked NMRA approvals.
- Strategic location: Proximity to both the Hambantota port and Mattala airport, with dedicated facilities at airport to facilitate sea-air logistics.
- Common facilities provided: Wastewater treatment & sea outfall and common logistics facilities
Project/ownership structure
Foreign Direct Investments (FDI), Domestic Private Investment
Project incentives:
Exemptions for Import Substitution under Value Added Tax (VAT), Port & Airport Levy (PAL), Customs Import Duty (CID), Commodity Export Subsidy Scheme (CESS)
Other incentives:
Strategic location
Proximity to both the Hambantota port and Mattala airport, with dedicated facilities at airport to facilitate sea-air logistics.State-of-the-art zone
This pharmaceutical zone in Arabokka, Hambantota will provide common facilities including wastewater treatment, a sea outfall and common logistics facilities.Approved activities
- Pharmaceuticals, medicinal chemical, and botanical products manufacturing facilities
- Production of medicines covering all therapeutic classes
- Production of APIs
- Secondary processing including intermediates, formulation, blending and packaging
- Production of radiopharmaceuticals (I-131, Tc-99m, F-18)
- Manufacturing of herbal/botanical products and indigenous medicine including Ayurvedic and homeopathic drugs
- Production of borderline products (products with combined characteristics of medicines along with foods, medical devices)
- Production of medicines covering all therapeutic classes
- Medical devices manufacturing or assembling facilities
- Related ancillary facilities R&D including biotechnology research and production and laboratory testing facilities